Big data to real world evidence: Informing pharmaceutical policy decisions around targeted cancer medicines

大数据与现实世界证据：为靶向癌症药物的制药政策决策提供信息

• 批准号: nhmrc : GNT1094325
• 负责人: Mr Benjamin Daniels
• 金额: $ 5.56万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/big-real-world-cancer-medicines/1345944
• 关键词: Big; data; real; world; evidence

The proposed research will examine the use of targeted cancer therapies in Australia. At present there is little evidence around how these medications are being used in the real world, medical services their use requires, and costs associated with their use. Analysing linked, routinely collected health data, this project will generate new scientific and methodological knowledge about the use and impact of targeted cancer therapies available via publicly funded access programs in Australia.

这项拟议的研究将检查澳大利亚靶向癌症疗法的使用情况。目前，几乎没有证据表明这些药物在现实世界中是如何使用的，它们的使用需要医疗服务，以及与它们的使用相关的成本。通过分析相关的、常规收集的健康数据，该项目将产生关于通过澳大利亚公共资助的ACCESS项目提供的靶向癌症疗法的使用和影响的新的科学和方法知识。